Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The prevalence of type 2 diabetes mellitus (T2DM) in Qatar and nations worldwide has
increased in recent decades into epidemic proportions. Cardiovascular (CVD) disease is the
leading cause of death in T2DM patients. Approximately 80% of T2DM patients will die because
of CV cause. Congestive heart failure (CHF) is a major cause of CV death in T2DM, and it also
is responsible for significant morbidity and health care expenditure due to high rate of
hospitalization for heart failure.